Your browser doesn't support javascript.
loading
Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations.
Lin, Guo-Wang; Xu, Caigang; Chen, Kexin; Huang, Hui-Qiang; Chen, Jieping; Song, Bao; Chan, John K C; Li, Wenyu; Liu, Weiping; Shih, Lee-Yung; Chuang, Wen-Yu; Kim, Won Seog; Tan, Wen; Peng, Rou-Jun; Laurensia, Yurike; Cheah, Daryl Ming Zhe; Huang, DaChuan; Cheng, Chee Leong; Su, Yi-Jiun; Tan, Soo-Yong; Ng, Siok-Bian; Tang, Tiffany Pooi Ling; Han, Kyudong; Wang, Vivien Ya-Fan; Jia, Wei-Hua; Pei, Zhong; Li, Ya-Jun; Gao, Song; Shi, Yongyong; Hu, Zhibin; Zhang, Furen; Zhang, Ben; Zeng, Yi-Xin; Shen, Hongbing; He, Lin; Ong, Choon Kiat; Lim, Soon Thye; Chanock, Stephen; Kwong, Yok-Lam; Lin, Dongxin; Rothman, Nathaniel; Khor, Chiea Chuen; Lan, Qing; Bei, Jin-Xin.
Afiliação
  • Lin GW; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Xu C; Hematology Research Laboratory, Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.
  • Chen K; Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Huang HQ; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Chen J; Department of Hematology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Song B; Department of Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Chan JKC; Department of Pathology, Queen Elizabeth Hospital, Hong Kong Special Administrative Region, China.
  • Li W; Department of Lymphoma, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Liu W; Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
  • Shih LY; Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan; Chang Gung University, Taoyuan.
  • Chuang WY; Department of Pathology, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan.
  • Kim WS; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Tan W; Department of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Peng RJ; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Laurensia Y; Lymphoma Genomic Translational Research Laboratory, Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore.
  • Cheah DMZ; Lymphoma Genomic Translational Research Laboratory, Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore.
  • Huang D; Lymphoma Genomic Translational Research Laboratory, Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore.
  • Cheng CL; Department of Pathology, Singapore General Hospital, Singapore.
  • Su YJ; Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan.
  • Tan SY; Department of Pathology, Guangdong Academy of Medical Sciences, Guangzhou, China; Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Pathology, National University Hospital, National University Health System, Singapore; Institute of M
  • Ng SB; Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Cancer Science Institute of Singapore, National University of Singapore, Singapore; Department of Pathology, National University Hospital, National University Health System, Singapore.
  • Tang TPL; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
  • Han K; Department of Nanobiomedical Science, BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan, South Korea.
  • Wang VY; Faculty of Health Sciences, University of Macau, Macau Special Administrative Region, China.
  • Jia WH; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Pei Z; Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Li YJ; Department of Lymphoma and Hematology, Hunan Cancer Hospital, Changsha, China; The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
  • Gao S; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Shi Y; The Affiliated Hospital of Qingdao University & the Biomedical Sciences Institute of Qingdao University, Qingdao Branch of SJTU Bio-X Institutes, Qingdao University, Qingdao, China; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Edu
  • Hu Z; Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Zhang F; Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.
  • Zhang B; Department of Epidemiology and Biostatistics, First Affiliated Hospital, Army Medical University, Chongqing, China.
  • Zeng YX; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Shen H; Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, School of Public Health, Nanjing Medical University, Nanjing, China.
  • He L; The Affiliated Hospital of Qingdao University & the Biomedical Sciences Institute of Qingdao University, Qingdao Branch of SJTU Bio-X Institutes, Qingdao University, Qingdao, China; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Edu
  • Ong CK; Lymphoma Genomic Translational Research Laboratory, Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore; Genome Institute of Singapore, Singapore; Duke-NUS Medical School, Singapore.
  • Lim ST; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, Singapore; SingHealth Duke-NUS Blood Cancer Centre, Singapore.
  • Chanock S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Kwong YL; Department of Medicine, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
  • Lin D; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; Department of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center/Cancer Hospital, Chinese Academy of Medica
  • Rothman N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Khor CC; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; Genome Institute of Singapore, Singapore; Singapore Eye Research Institute, Singapore.
  • Lan Q; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Bei JX; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China; Division of Medical Oncology, National Cancer Centre Sing
Lancet Oncol ; 21(2): 306-316, 2020 02.
Article em En | MEDLINE | ID: mdl-31879220
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Proliferação de Células / Subunidade beta de Receptor de Interleucina-18 / Linfoma Extranodal de Células T-NK / Células T Matadoras Naturais Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Proliferação de Células / Subunidade beta de Receptor de Interleucina-18 / Linfoma Extranodal de Células T-NK / Células T Matadoras Naturais Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido